BHVN FY 2024 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$885M

Net Income

-$846M

EPS (Diluted)

$-9.28

Cash Flow

Operating Cash Flow

-$582M

Free Cash Flow

-$587M

Stock-Based Comp.

$72M

Balance Sheet

Total Assets

$615M

Total Liabilities

$192M

Stockholders' Equity

$423M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$885M	-$436M	-103.0%
Net Income	-$846M	-$408M	-107.4%